Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-01 Hoge Stephen President Sale −1,072 $138.03 $148K 1,629,031
2023-02-28 Klinger Shannon Thyme Chief Legal Officer Grant or award · Stock Option (Right to Buy) +20,040 20,040
2023-02-28 Klinger Shannon Thyme Chief Legal Officer Grant or award · Restricted Stock Units +5,260 5,260
2023-02-28 Hoge Stephen President Exercise or conversion +2,410 1,630,103
2023-02-28 Hoge Stephen President Exercise or conversion · Restricted Stock Units −2,410 9,643
2023-02-28 Hoge Stephen President Grant or award · Stock Option (Right to Buy) +37,217 37,217
2023-02-28 Hoge Stephen President Grant or award · Restricted Stock Units +9,768 9,768
2023-02-28 Mock James M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +20,040 20,040
2023-02-28 Mock James M Chief Financial Officer Grant or award · Restricted Stock Units +5,260 5,260
2023-02-28 Garay Arpa Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +20,040 20,040
2023-02-28 Garay Arpa Chief Commercial Officer Grant or award · Restricted Stock Units +5,260 5,260
2023-02-28 Bancel Stephane Chief Executive Officer Grant or award · Stock Option (Right to Buy) +128,830 128,830
2023-02-23 Bancel Stephane Chief Executive Officer Exercise or conversion +40,000 $0.99 $40K 5,451,946
2023-02-23 Bancel Stephane Chief Executive Officer Sale −7,314 $144.45 $1.1M 5,444,632
2023-02-23 Bancel Stephane Chief Executive Officer Sale −7,486 $145.25 $1.1M 5,437,146
2023-02-23 Bancel Stephane Chief Executive Officer Sale −12,890 $146.75 $1.9M 5,424,256
2023-02-23 Bancel Stephane Chief Executive Officer Sale −8,256 $147.43 $1.2M 5,416,000
2023-02-23 Bancel Stephane Chief Executive Officer Sale −3,754 $148.27 $557K 5,412,246
2023-02-23 Bancel Stephane Chief Executive Officer Sale −300 $149.86 $45K 5,411,946
2023-02-23 Bancel Stephane Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −40,000 1,387,155

Page 55 of 66 · 1,314 trades